Laboratoires Juvisé Pharmaceuticals
Privately held: no public share price · France
Assets
(2 total)
2Total Assets
2Approved
0Phase 3 / Filed
0Phase 1–2 / Early
4Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Approved | AromataseSmall molecule | Breast Cancer HR+/HER2- Metastatic Breast Cancer | |
| Approved | S1P receptorSmall molecule | Inflammatory Bowel DiseasePsoriasisMultiple Sclerosis Ulcerative Colitis |
Upcoming events
(3 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2028 (1)
2029 (2)
April 2029 (1)
December 2029 (1)
Est. primary completion 2029-12-18 · NCT06380751 · CT.gov ↗
What to watch
Financial reports
No financial reports recorded.